Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Krishna, Vagolu Siva
Rekha, Estharla Madhu
Guddat, Luke W.
Text and Data Mining valid from 2019-01-21
12 July 2018
2 January 2019
21 January 2019
Compliance with ethical standards
The authors declare no conflict of interest.